Xbiotech Inc (XBIT) Institutional Ownership & 13F Filings (Q2 2026)

XBIT ranks #6948 out of 37505 tracked stocks by institutional interest, inside the more closely watched half of our coverage.

37 institutions disclose a position in XBIT, but none treat it as a major bet — even RBF Capital, LLC, its most concentrated holder, allocates just 0.0% of its own portfolio to it.

Royal Bank Of Canada has added to its XBIT position for two straight quarters, increasing it by $3.0K to reach $3.0K today.

Israel Englander has trimmed its XBIT position for two straight quarters, cutting it by $141.2K while still holding $182.5K.

XBIT reported a net loss of $45.5M in its latest fiscal year.

• Not yet profitable — net loss of $45.5M in the latest fiscal year
• Net income declined year over year, from -$38.5M to -$45.5M
• Operating cash flow was negative, using $39.9M in cash
• Current ratio of 16.01x — enough short-term assets to cover short-term liabilities
• Liabilities run 0.07x equity — within a conventional range